Multidrug-Resistant Bacteria in the Community: An Update

Infect Dis Clin North Am. 2020 Dec;34(4):709-722. doi: 10.1016/j.idc.2020.08.002. Epub 2020 Sep 30.

Abstract

Multidrug-resistant bacteria are among the most important current threats to public health. Typically, they are associated with nosocomial infections. However, some have become prevalent causes of community-acquired infections, such as Neisseria gonorrhoeae, Shigella, Salmonella, and Streptococcus pneumoniae. The community spread of multidrug-resistant bacteria is also a crucial development. An important global threat on the horizon is represented by production of carbapenemases by community-acquired hypervirulent Klebsiella pneumoniae. Such strains have already been found in Asia, Europe, and North America. Prevention of further community spread of multidrug-resistant bacteria is of the utmost importance, and will require a multidisciplinary approach involving all stakeholders.

Keywords: Carbapenem resistant Enterobacteriaceae; Gonococcus; K pneumoniae; MRSA.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Agriculture
  • Bacteria / classification*
  • Bacteria / genetics
  • Bacteria / isolation & purification
  • Community-Acquired Infections / microbiology*
  • Cross Infection / microbiology*
  • Drug Resistance, Multiple, Bacterial*
  • Escherichia coli / classification
  • Escherichia coli / genetics
  • Escherichia coli / isolation & purification
  • Global Health
  • Humans
  • Klebsiella pneumoniae / classification
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / isolation & purification
  • Methicillin-Resistant Staphylococcus aureus / classification
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Prevalence